06/11/2024
7:15 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:44 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
4:31 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
6:38 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/09/2024
3:39 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:07 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:49 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/07/2024
8:53 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:44 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:47 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:48 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:09 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:54 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:58 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:28 PM | Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:32 PM | Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:34 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:44 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:47 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:50 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:52 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:11 PM | Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/05/2024
6:14 PM | Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/01/2024
2:11 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:06 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
6:46 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
6:29 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/25/2024
4:01 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/19/2024
5:19 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:21 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:23 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:25 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:28 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:33 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
3:39 PM | Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
3:31 PM | Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
6:36 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
$16T Crypto Plot From Elon Musk (Ad) Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market.
Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account."
Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. |
09/11/2023
12:33 PM | Jazz Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
09/06/2023
4:09 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
3:39 PM | Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/31/2023
5:44 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
4:41 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023
4:21 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
6:49 PM | Jazz Pharmaceuticals (Issuer)
O'Keefe Kenneth W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
6:51 PM | Jazz Pharmaceuticals (Issuer)
ORiordan Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
4:58 PM | Jazz Pharmaceuticals (Issuer)
RIEDEL NORBERT G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
5:00 PM | Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
5:02 PM | Jazz Pharmaceuticals (Issuer)
Sohn Catherine A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
5:08 PM | Jazz Pharmaceuticals (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
4:47 PM | Gray Peter (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
4:49 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
4:52 PM | Jazz Pharmaceuticals (Issuer)
McSharry Heather Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
4:56 PM | Jazz Pharmaceuticals (Issuer)
Mulligan Seamus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
4:40 PM | Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
4:43 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
4:44 PM | Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
4:45 PM | ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
8:55 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
8:35 PM | Jazz Pharmaceuticals (Subject)
Winningham Rick E (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
8:40 PM | Gray Peter (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
8:28 PM | ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
8:00 PM | Jazz Pharmaceuticals (Subject)
McSharry Heather Ann (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
8:04 PM | Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
8:09 PM | Jazz Pharmaceuticals (Subject)
O'Keefe Kenneth W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
8:15 PM | Jazz Pharmaceuticals (Subject)
Smith Mark Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
8:19 PM | Jazz Pharmaceuticals (Subject)
RIEDEL NORBERT G (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
7:54 PM | Jazz Pharmaceuticals (Subject)
Sohn Catherine A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
7:36 PM | Jazz Pharmaceuticals (Subject)
ORiordan Anne (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
5:41 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/22/2023
3:05 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
